P

Inventor

DURING MATTHEW J

US14 patents
⚠️ This page may combine multiple inventors who share the name “DURING MATTHEW J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV ROCKEFELLER

3 patents
US6503888B1Jan 7, 2003

AAV-mediated delivery of DNA to cells of the nervous system

UNIV ROCKEFELLER140 citations98
US6180613B1Jan 30, 2001

AAV-mediated delivery of DNA to cells of the nervous system

UNIV ROCKEFELLER488 citations98
US8021838B2Sep 20, 2011

Transcriptional regulation of target genes

UNIV ROCKEFELLER1 citations51

NEUROLOGIX INC

2 patents
US6329181B1Dec 11, 2001

Helper functions for recombinant vector production

NEUROLOGIX INC37 citations92
US7723288B2May 25, 2010

Methods and compositions for the treatment of neurological disease

NEUROLOGIX INC8 citations76

UNIV JEFFERSON

2 patents
US6780409B2Aug 24, 2004

Glutamic acid decarboxylase (GAD) based delivery system

UNIV JEFFERSON21 citations90
US7655619B2Feb 2, 2010

Insulin-associated peptides with effects on cerebral health

UNIV JEFFERSON22 citations87

(unassigned)

1 patent
US6436708B1Aug 20, 2002

Delivery system for gene therapy to the brain

197 citations96

MASSACHUSETTS INST TECHNOLOGY

1 patent
US5601835AFeb 11, 1997

Polymeric device for controlled drug delivery to the CNS

MASSACHUSETTS INST TECHNOLOGY92 citations94

DURING MATTHEW

1 patent
US6503887B1Jan 7, 2003

Peroral gene therapy of diabetes and obesity

DURING MATTHEW20 citations88

KAPLITT MICHAEL G

1 patent
US8182460B2May 22, 2012

Infusion device and method for infusing material into the brain of a patient

KAPLITT MICHAEL G6 citations70

DURING MATTHEW J

1 patent
US9265843B2Feb 23, 2016

Treatment of metabolic-related disorders using hypothalamic gene transfer of BDNF and compositions therefor

DURING MATTHEW J5 citations68

GEN HOSPITAL CORP

1 patent
US6265442B1Jul 24, 2001

Treatment of neurological diseases by increasing brain concentrations of kynurenic acid

GEN HOSPITAL CORP9 citations65

AUCKLAND TECHNOLOGY ENABLING CORP

1 patent
US7935333B2May 3, 2011

Method and compositions for modifying target receptor function associated with neurological disorders

AUCKLAND TECHNOLOGY ENABLING CORP3 citations56